|
KIAA1328 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62669877568078E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63202784619898E-12 |
| Normal-vs-Stage2 |
1.99840144432528E-15 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.6269208202857E-12 |
| Stage1-vs-Stage2 |
1.077820E-01 |
| Stage1-vs-Stage3 |
5.373000E-01 |
| Stage1-vs-Stage4 |
2.510000E-01 |
| Stage2-vs-Stage3 |
2.903600E-01 |
| Stage2-vs-Stage4 |
6.587800E-01 |
| Stage3-vs-Stage4 |
5.329800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62680979798324E-12 |
| Normal-vs-AfricanAmerican |
1.81572999999879E-05 |
| Normal-vs-Asian |
3.61455310127212E-12 |
| Caucasian-vs-AfricanAmerican |
3.205900E-02 |
| Caucasian-vs-Asian |
5.231000E-01 |
| AfricanAmerican-vs-Asian |
1.692000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-16 |
| Normal-vs-Female |
1.62836411021772E-12 |
| Male-vs-Female |
2.900600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.32667268468867E-15 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.92130000004265E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.532800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.416200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.023400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.291600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.759400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.969000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.080240E-03 |
| Classical-VS-Follicular |
1.898040E-03 |
| Classical-VS-Other |
2.473200E-01 |
| Classical-VS-Normal |
4.32431868091498E-13 |
| Tall-VS-Follicular |
8.570000E-01 |
| Tall-VS-Other |
8.899000E-01 |
| Tall-VS-Normal |
3.33066907387547E-16 |
| Follicular-VS-Other |
9.796800E-01 |
| Follicular-VS-Normal |
1.62436730732907E-12 |
| Other-VS-Normal |
7.50850000000858E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.42978986825437E-14 |
| N0-vs-N1 |
8.084800E-01 |
|
|
